Who should NOT take orforglipron
Absolute contraindications and cautions
Quick read · 7 min
Do not take orforglipron if you have a personal or family history of medullary thyroid cancer (MTC), Multiple Endocrine Neoplasia type 2 (MEN 2), or are pregnant. Use caution if you have diabetic eye disease, a history of pancreatitis, or severe kidney disease.
- •Absolute "do not take": MTC history, MEN 2, pregnancy, severe pancreatitis history
- •Use with caution: Diabetic retinopathy, gallbladder disease, severe kidney disease, severe GI problems
- •Orforglipron can lower blood sugar — insulin doses may need adjustment
- •Oral contraceptive pills: talk to your doctor about potential interaction
- •Tell your doctor: thyroid history, allergies, other medications, eating disorders
Based on clinical trials · No rankings · Every claim linked to source
Semaglutide and tirzepatide can cause thyroid C-cell tumours in rodents. This has not been observed in humans, but the FDA requires this warning.
Who is at risk: People with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2). If this is you, do not take this medication.
Do NOT take if you have:
These are absolute contraindications. Talk to your doctor before starting if any apply to you.
MTC is a rare thyroid cancer. Orforglipron carries an FDA warning for thyroid C-cell tumours (shown in animals, not confirmed in humans). If you have personal history, do not take this drug. If multiple relatives had MTC, get genetic testing for MEN 2 first.
MEN 2 is a genetic syndrome that increases thyroid cancer risk. If you have MEN 2, orforglipron is contraindicated. Ask your doctor about genetic testing if you have a strong family history of thyroid cancer.
Orforglipron causes birth defects in animal studies. Stop at least 2 months before trying to conceive. If you become pregnant while taking it, stop immediately and contact your doctor.
If you have had acute pancreatitis, orforglipron carries a risk of triggering it again. Talk to your doctor — the risk-benefit may not favour this drug.
If you have had anaphylaxis, swelling of the throat, or severe rash from orforglipron or any GLP-1 drug, do not take it. Tell your doctor immediately.
Pregnancy and breastfeeding
Talk to your doctor about weight loss options if you are planning pregnancy or breastfeeding. Other approaches may be safer.
Talk to your doctor if you have:
These are not automatic contraindications, but require a conversation with your doctor before starting.
Orforglipron can worsen existing diabetic retinopathy, especially if blood sugar drops quickly. Most relevant if you have type 2 diabetes with existing eye damage. Your doctor will monitor your eyes. This is not an absolute contraindication — just needs careful monitoring.
Rapid weight loss increases gallstone formation risk. If you have a history of gallstones, your doctor may monitor with ultrasounds. Not an absolute contraindication, but requires discussion.
Orforglipron may affect stomach function; severe GI conditions require careful discussion with your doctor. Mild GI issues (like IBS) are usually fine.
Limited data on orforglipron in severe kidney disease. Your doctor may recommend caution or dose adjustment. Mild to moderate kidney disease is usually okay with monitoring.
A baseline thyroid ultrasound may be recommended before starting. Thyroid monitoring during treatment is reasonable. Not an absolute contraindication, but requires discussion.
Quick eligibility summary
Likely a good fit if:
- •BMI 30+ (or 27+ with obesity-related conditions)
- •No personal or family history of MTC / MEN 2
- •Not pregnant or planning pregnancy within 2 months
- •Prefer a pill over injections
- •No severe kidney, liver, or pancreatic disease
Talk to your doctor if:
- •You have a family history of thyroid cancer
- •You have diabetic eye disease or retinopathy
- •You have a history of gallstones
- •You take insulin or diabetes medications
- •You take oral contraceptive pills
Not for you if:
- •Personal or family history of MTC
- •Known MEN 2 syndrome
- •Currently pregnant or planning pregnancy soon
- •Severe pancreas or kidney disease
- •Severe allergy to orforglipron or GLP-1 drugs
Next step most people take
Based on clinical trials · No rankings · Every claim linked to source
Last reviewed: March 2026